HIV Infection Care and Viral Suppression Among People Who Inject Drugs, 28 U.S. Jurisdictions, 2012-2013
The Open AIDS Journal · 15.06.2016 · 10 (1) · 127-135
DOI: 10.2174/1874613601610010127 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Open AIDS Journal, erschienen am 15.06.2016. Verfasst von Debra L Karch und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Atlanta, GA, 30329, USA. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
Assess outcomes along the care continuum for HIV-infected people who inject drugs (PWID), by type of facility and stage of infection at diagnosis.
Methods
Data reported by 28 jurisdictions to the National HIV Surveillance System by December 2014 were used to identify PWID aged ≥13 years, diagnosed with HIV infection before December 31, 2013. Analyses used the CDC definition of linkage to care (LTC), retention in care (RIC), and viral suppression (VS), and are stratified by age, sex, race/ethnicity, and type of facility and stage of HIV infection at diagnosis.
Results
Of 1,409 PWID diagnosed with HIV in 2013, 1,116 (79.2%) were LTC with the lowest percentages among males (78.4%); blacks (77.5%) ages 13-24 years (69.0%); those diagnosed in early stage infection (71.6%); and at screening, diagnostic, or referral agencies (60.0%). Of 80,958 PWID living with HIV in 2012, 40,234 (49.7%) were RIC and 34,665 (42.8%) achieved VS. The lowest percentages for RIC and VS were among males (47.1% and 41.3% respectively); those diagnosed with late stage disease (47.1% and 42.4%); and young people. Whites had the lowest RIC (47.0%) while blacks had the lowest VS (41.1%).
Conclusion
Enhanced LTC activities are needed for PWID diagnosed at screening, diagnostic or referral agencies versus those diagnosed at inpatient or outpatient settings, especially among young people and blacks diagnosed in early stage infection. Less than half of PWID are retained in care or reach viral suppression indicating the need for continued engagement and return to care activities over the long term.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Atlanta, GA, 30329, USA.
- ICF International, Inc, Atlanta, GA, 30329, USA.
Zitieren
APA
Karch, D. L., Gray, K. M., Shi, J., & Hall, H. I. (2016). HIV Infection Care and Viral Suppression Among People Who Inject Drugs, 28 U.S. Jurisdictions, 2012-2013. The Open AIDS Journal, 10(1), 127-135. https://doi.org/10.2174/1874613601610010127
Vancouver
Karch DL, Gray KM, Shi J, Hall HI. HIV Infection Care and Viral Suppression Among People Who Inject Drugs, 28 U.S. Jurisdictions, 2012-2013. The Open AIDS Journal. 2016;10(1):127-135. doi:10.2174/1874613601610010127
BibTeX
@article{Karch2016,
author = {Karch, Debra L and Gray, Kristen Mahle and Shi, Jing and Hall, H Irene},
title = {HIV Infection Care and Viral Suppression Among People Who Inject Drugs, 28 U.S. Jurisdictions, 2012-2013},
journal = {The Open AIDS Journal},
year = {2016},
volume = {10},
number = {1},
pages = {127--135},
doi = {10.2174/1874613601610010127}
}
EUVIMED